BIOMARIN PHARMACEUTICAL Stock Quote

$92.33 arrow  Change: 4.03 %Chge: 4.56% Vol: 122,588
End Of Day Prices
High: 92.8 | Low: 90.5 | Open: 91.63 | Close: 92.33
52 Wk High: 99.9 | 52 Wk Low: 75.94 | Todays Pivot: 91.88
Sector: Healthcare and Pharmaceuticals add stock to watch list

BMRN Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Aetna 105.5 green arrow 130,885
Idexx Labs 87.52 green arrow 24,564
Charles Riv Labs Intl 81.82 green arrow 15,841
Patterson Companies 45.9  arrow 100,375
Waters 188.84 green arrow 42,277
Waters 154.89 red arrow 24,061
Valeant Pharmaceuticals Intl I 12.2 red arrow 553,367
Amylin Pharmaceuticals 15.8  arrow 440,180

Above is a small selection of related companies to Biomarin Pharmaceutical which compete alongside BMRN within the Healthcare and Pharmaceuticals sector. To see more related companies to BMRN, view our stock market today information page.

Online News For Biomarin Pharmaceutical

Credit Suisse Reconfirmed Biomarin Pharmaceutical (NASDAQ:BMRN) As a “Outperform”; They Now Have a Target Of $120

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.08, from 1.13 in 2017Q3. It increased, as 37 investors sold BioMarin Pharmaceutical Inc. shares while 112 reduced holdings. 51 funds opened positions while 130 raised stakes. 172.01 million shares ...


Today Canaccord Genuity Maintains a “Buy” Rating on Biomarin Pharmaceutical (NASDAQ:BMRN) and a $105 Target Price

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.08, from 1.13 in 2017Q3. It increased, as 37 investors sold BioMarin Pharmaceutical Inc. shares while 112 reduced holdings. 51 funds opened positions while 130 raised stakes. 172.01 million shares ...


Nasdaq 100 Movers: ROST, BMRN

In early trading on Friday, shares of BioMarin Pharmaceutical topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.9%. Year to date, BioMarin Pharmaceutical Inc. registers a 2.9% gain. And the worst performing ...


BioMarin Pharma (BMRN) Receives Standard Approval for Palynziq Injection for Treatment of Adults with Phenylketonuria

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that BioMarin received standard approval from the U.S. Food and Drug Administration ...


Nasdaq 100 Movers: BMRN, MU

In early trading on Tuesday, shares of Micron Technology ( MU) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 6.9%. Year to date, Micron Technology registers a 44.2% gain. And the worst performing Nasdaq 100 ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Biomarin Pharmaceutical quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BMRN to choose from. Visit here to build your stock quote widget »